Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Lyra Therapeutics (LYRA) Free Cash Flow (2021 - 2025)

Lyra Therapeutics has reported Free Cash Flow over the past 5 years, most recently at -$6.2 million for Q4 2025.

  • Quarterly results put Free Cash Flow at -$6.2 million for Q4 2025, up 45.44% from a year ago — trailing twelve months through Dec 2025 was -$29.0 million (up 59.98% YoY), and the annual figure for FY2025 was -$29.0 million, up 59.95%.
  • Free Cash Flow for Q4 2025 was -$6.2 million at Lyra Therapeutics, up from -$7.4 million in the prior quarter.
  • Over the last five years, Free Cash Flow for LYRA hit a ceiling of $2.8 million in Q2 2021 and a floor of -$22.8 million in Q1 2024.
  • Median Free Cash Flow over the past 5 years was -$11.6 million (2022), compared with a mean of -$11.9 million.
  • Biggest five-year swings in Free Cash Flow: crashed 404.17% in 2022 and later soared 66.54% in 2025.
  • Lyra Therapeutics' Free Cash Flow stood at -$13.6 million in 2021, then rose by 10.57% to -$12.2 million in 2022, then plummeted by 61.36% to -$19.7 million in 2023, then skyrocketed by 42.59% to -$11.3 million in 2024, then soared by 45.44% to -$6.2 million in 2025.
  • The last three reported values for Free Cash Flow were -$6.2 million (Q4 2025), -$7.4 million (Q3 2025), and -$6.6 million (Q2 2025) per Business Quant data.